Availability in the acute setting (0–6 hours) |
++ |
− |
Rapid image acquisition |
++ |
+ |
Lack of vulnerability to motion artifact |
+ |
− |
Accessibility for patients with monitors and/or ventilators |
++ |
− |
Feasibility and safety for patients with metallic implants (pacemakers, implantable defibrillators) |
++ |
− |
Lower cost |
+ |
− |
Lack of ionizing radiation |
− |
++ |
Renal toxicity associated with contrast administration |
+ |
+ |
Time for post-processing angiography and perfusion imaging |
− |
− |
Sensitivity to lacunar and posterior fossa infarcts |
− |
++ |
Differentiation between acute and chronic ischemia |
− |
++ |
Ability to assess causes of ICH or SAH while in the scanner |
+ |
+ |
Detection of chronic hemorrhage including microbleeds |
− |
+ |